Skip to content
Screener

Odyssey Therapeutics ODTX Current ratio

Current ratio at other companies

AutoZone logo
AutoZoneAZO
0.9×0.0×
Synopsys logo
SynopsysSNPS
1.4×-5.6×
Nucor logo
NucorNUE
2.9×+0.4×
Dycom Industries logo
Dycom IndustriesDY
2.6×-0.3×
Nordson logo
NordsonNDSN
2.6×0.0×
Cardinal Health logo
Cardinal HealthCAH
0.9×0.0×

Other financials

Income statement

See full
Revenue--100%
Operating income-$55.5M-32.3%
Net income-$52.8M-28.0%
EPS (diluted)-$1.74+94.1%

Balance sheet

See full
Cash & equivalents$82.0M-49.7%
Total debt$24.8M+8,175%
Total equity$421.2M+197%
Total assets$483.9M—

Cash flow

See full
Operating cash flow-$34.5M-0.7%
CapEx$186.0K+541%
Free cash flow-$34.7M-1.2%

Valuation

See full
Market cap$1B+27.8%
Enterprise value$946.17M—
P/S348.8×—

Profitability

See full
Operating margin-6,129%—
Net margin-5,934%—
FCF margin-5,203.9%—

Returns & leverage

See full
Return on equity-8,434.8%—
Debt / equity0.1×—

Where this comes from

Calculated from Odyssey Therapeutics’s reported figures.

total current assets/total current liabilities=11.4×

Based on the most recent quarter.

The source filing: Odyssey Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 5, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335822

FAQ

What is Odyssey Therapeutics's current ratio?
Odyssey Therapeutics (ODTX) reported current ratio of 11.4× in Q2 2026.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Ask your AI about Odyssey Therapeutics's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude